Our blog

logo

Evaluation of an inhibitor of the LRRK 2 gene in Parkinson’s patients. Oral tract. We…

Compartir:
logo

Trial on LRRK2 mutation in Parkinson’s is about to be completed. Our Trials Unit is…

Compartir:
logo

Trial on LRRK2 mutation in Parkinson’s disease is about to be completed. Our Clinical Trials…

Compartir:
logo

Highly positive results from the pivotal Phase III BouNDless trial evaluating ND0612 in patients with…

Compartir:
logo

The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured…

Compartir:
Area privada5

On Epiphany, the U.S. Food and Drug Administration approved a new drug for early-stage Alzheimer’s…

Compartir:
Area privada1

The General University Hospital of Catalonia is the first recognized center in Europe to evaluate…

Compartir:
Blogudic1

This study could improve the efficacy and safety of the products being evaluated to try…

Compartir:
logo

The FDA has approved the use of sublingual apomorphine (KYNMOBI) in motor blocks, in Parkinson’s…

Compartir:
nota legal

An intranasal levodopa has been authorized in the US to treat off blockages, called Inbrija….

Compartir:
Proyectos1

Levodopa infusion pump We evaluate an ultraconcentrated levodopa administered subcutaneously in patients with motor fluctuations….

Compartir:
Area privada1

Our Unit has achieved to be activated in this outstanding project and so serious pathology….

Compartir:
Page 1 of 41 2 3 4

Compartir: